Beranda › Skizofrenia › Texas
Uji klinis Skizofrenia di Texas
34 studi untuk Skizofrenia mencari peserta di lokasi di Texas.
Kota di Texas
Teks studi resmi (Bahasa Inggris)
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- Haracec Clinical Research, El Paso
- C-Trilogy Outreach, Longview
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07101094A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Community Clinical Research, Inc., Austin
- Pillar Clinical Research, LLC, Richardson
Menerima pesertaFase 1
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07615426Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Local Institution - 0049, Austin
- Local Institution - 0194, Dallas
- Pillar Clinical Research - Richardson, Richardson
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07686263Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Texas Research Group, Coppell
- PsyMed Solutions, Fort Worth
- Kaleidoscope Clinical Research, Houston
- dan 3 lainnya
Menerima pesertaFase 3
Usia 5 hingga 17 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06229210NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Austin
- Neurocrine Clinical Site, DeSoto
- Neurocrine Clinical Site, Houston
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07114874Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, DeSoto
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07227818Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
- TG Therapeutics Investigational Trial Site, Richardson
Menerima pesertaFase 2
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07680946A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0149, Dallas
- VAST Clinical Research, Garland
- Local Institution - 0169, Houston
- dan 2 lainnya
Menerima pesertaFase 3
Usia 5 hingga 17 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07424404A Study of Brenipatide in Adult Participants With Schizophrenia
- Adams Clinical Dallas, DeSoto
- Re:Cognition Health - Fort Worth, Fort Worth
Menerima pesertaFase 2
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07410507A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Austin
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- Pillar Clinical Research, LLC, Richardson
Menerima pesertaFase 1
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07734493Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
- The University of Texas Health Science Center, Houston, Houston
Menerima peserta
Usia 22 hingga 65 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT05276050A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- Community Clinical Research - Cross Park Drive /ID# 272977, Austin
- Pillar Clinical Research - Richardson /ID# 275715, Richardson
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT0714591852-week Open Label Safety-Tolerability Study
- Adams Clinical, DeSoto
- Pillar Clinical Research, Richardson
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- VAST Clinical Research, Garland
- Local Institution - 0120, Houston
- Local Institution - 0066, Spring
Menerima pesertaFase 3
Usia 13 hingga 17 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07288567A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- Community Clinical Research, Austin
Menerima pesertaFase 1
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07061288A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Austin
- Clinical Site, DeSoto
- Clinical Site, Richardson
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Local Institution - 0016, Austin
- Local Institution - 0050, Dallas
- Local Institution - 0021, Fort Worth
- dan 10 lainnya
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07379827Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- BioXcel Clinical Research Site, DeSoto
Menerima pesertaFase 1
Usia 10 hingga 17 · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT05025605Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia
- The University of Texas Health Science Center at Houston, Houston
Menerima peserta
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT07060066Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment
- The University of Texas Health Science Center at Houston, Houston
Menerima peserta
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT02916810Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)
- The University of Texas Health Science Center, Houston, Houston
Menerima peserta
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT06961916Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
- The University of Texas Health Science Center, Houston, Houston
Menerima peserta
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT06345963A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Community Clinical Research, Austin
Menerima pesertaFase 2
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT07191483Deep Brain Stimulation for Psychosis
- UT Southwestern Medical Center, Dallas
Menerima peserta
Usia 22 hingga 70 · Semua jenis kelamin · Diperbarui 9 Jun 2026 · NCT06257056A Study to Evaluate the Effect of KarXT on Urological Safety
- Local Institution - 0001, Austin
- InSite Clinical Research, DeSoto
Menerima pesertaFase 4
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT07221877CLOZAPINE Response in Biotype-1
- UT Southwestern Medical Center, Dallas
Menerima pesertaFase 4
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT04580134Database Registry for Neural Network Biomarkers in Psychosis
- University of Texas Southwestern Medical Center, Dallas
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT01409109Ocrelizumab for Psychosis by Autoimmunity
- Houston Methodist Research Institute, Houston
Menerima pesertaFase 1/2
Usia 18 hingga 35 · Semua jenis kelamin · Diperbarui 1 Apr 2026 · NCT03971487Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Texas Southwestern Medical Center, Dallas
Menerima pesertaStudi observasional
Usia 18 hingga 40 · Semua jenis kelamin · Diperbarui 10 Mar 2026 · NCT06740383NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Austin
- Neurocrine Clinical Site, DeSoto
- Neurocrine Clinical Site, Houston
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 6 Mar 2026 · NCT06963034Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
- University of Texas at Dallas, Dallas
Menerima peserta
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 23 Jan 2026 · NCT07098169Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Austin
- Vanda Investigational Site, Houston
- Vanda Investigational Site, Irving
- dan 1 lainnya
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 12 Jan 2026 · NCT06961968Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Austin
- Reviva site, Richardson
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 19 Des 2024 · NCT05184335Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.